Literature DB >> 2139764

Problems in diagnosis and management of desmoid tumors.

R Lopez1, N Kemalyan, H S Moseley, D Dennis, R M Vetto.   

Abstract

Thirty-two primary desmoid tumors occurred in 29 patients. The median patient age was 32 years, and 55% of the patients were females. An antecedent history of trauma at the tumor site was elicited from 28% of patients. Thirty-one of 32 primary tumors were completely excised at initial presentation. Five tumors were treated with adjuvant radiotherapy. The overall recurrence rate for primary and recurrent lesions was 60%. The recurrence rate in children (88%) was more than twice that found in adults (38%). A single recurrence did not significantly increase the likelihood of a subsequent recurrence. Greater than 90% of all recurrences took place within 3 years of treatment. The rate of recurrence was not clearly influenced by the status of histologic margins, although this was examined in less than half the tumors. Desmoid tumors are aggressive neoplasms that exhibit a strong propensity for local recurrence. They should be treated as low-grade malignancies with documentation of histologic margins and close clinical follow-up within the framework of a tumor registry.

Entities:  

Mesh:

Year:  1990        PMID: 2139764     DOI: 10.1016/s0002-9610(05)81243-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  38 in total

1.  Port site desmoid tumour following laparoscopic cholecystectomy: A case report.

Authors:  Gautham Krishnamurthy; Vijay Chetan Jha; Ganga Ram Verma
Journal:  J Minim Access Surg       Date:  2018 Jul-Sep       Impact factor: 1.407

2.  Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.

Authors:  Aimee M Crago; Juliann Chmielecki; Mara Rosenberg; Rachael O'Connor; Caitlin Byrne; Fatima G Wilder; Katherine Thorn; Phaedra Agius; Deborah Kuk; Nicholas D Socci; Li-Xuan Qin; Matthew Meyerson; Meera Hameed; Samuel Singer
Journal:  Genes Chromosomes Cancer       Date:  2015-07-14       Impact factor: 5.006

3.  Desmoid tumors -- a characterization of patients seen at Mayo Clinic 1976-1999.

Authors:  Taya Fallen; Marcia Wilson; Bruce Morlan; Noralane M Lindor
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

4.  Prognostic factors for desmoid tumor: a surgical series of 233 patients at a single institution.

Authors:  Wei-Gen Zeng; Zhi-Xiang Zhou; Jian-Wei Liang; Hui-Rong Hou; Zheng Wang; Hai-Tao Zhou; Xing-Mao Zhang; Jun-Jie Hu
Journal:  Tumour Biol       Date:  2014-05-02

5.  Intra-abdominal desmoid tumor mimicking locoregional recurrence after colectomy in a patient with sporadic colon cancer: report of a case.

Authors:  Rei Mizuno; Takashi Akiyoshi; Hiroya Kuroyanagi; Yoshiya Fujimoto; Masashi Ueno; Masatoshi Oya; Hiroaki Kanda; Toshiharu Yamaguchi
Journal:  Surg Today       Date:  2011-05-01       Impact factor: 2.549

Review 6.  A guide to oncological management of soft tissue tumours of the abdominal wall.

Authors:  K J Williams; A J Hayes
Journal:  Hernia       Date:  2013-09-17       Impact factor: 4.739

7.  [Extra-abdominal desmoid tumors. Case report and literature review].

Authors:  J Ridders; A Ernst; I Todt; R O Seidl
Journal:  HNO       Date:  2005-07       Impact factor: 1.284

8.  A prognostic nomogram for prediction of recurrence in desmoid fibromatosis.

Authors:  Aimeé M Crago; Brian Denton; Sébastien Salas; Armelle Dufresne; James J Mezhir; Meera Hameed; Mithat Gonen; Samuel Singer; Murray F Brennan
Journal:  Ann Surg       Date:  2013-08       Impact factor: 12.969

9.  Desmoid infilterating ileum, a rare complication.

Authors:  Tejaswini Vallabha; Vikram Sindgikar; Ramakant Baloorkar; Mandar Dhamangoankar; Uday Karjol
Journal:  Indian J Surg       Date:  2012-06-23       Impact factor: 0.656

Review 10.  Updates on abdominal desmoid tumors.

Authors:  Bernardino Rampone; Corrado Pedrazzani; Daniele Marrelli; Enrico Pinto; Franco Roviello
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.